col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


36 Results       Page 1

 [1] 
IMR Press: Frontiers in Bioscience-Landmark
  original article Date Title Authors   All Authors
1 [GO] 2024―May―24 Exploring the S Protein of SARS-CoV-2 to Design a Novel Multi-Epitope Vaccine against COVID-19 Based on Immunoinformatics Approaches Zhuanqing Huang, Haoyuan Shi, Hui Gong, Qi Sun, Sen Yang, Ying Zhang, et al. (+5)
2 [GO] 2024―Mar―22 From Sleep Deprivation to Severe COVID-19: A Comprehensive Analysis of Shared Differentially Expressed Genes and Potential Diagnostic Biomarkers Jing Peng, Xiaocheng Zhu, Wuping Zhuang, Hui Luo, E Wang
3 [GO] 2024―Feb―06 SARS-CoV-2 Infection is Associated with Age- and Gender-Specific Changes in the Nasopharyngeal Microbiome Silvia Bozza, Emilia Nunzi, Abel Frias-Mazuecos, Giuseppe Pieraccini, Marilena Pariano, Giorgia Renga, et al. (+6)
4 [GO] 2024―Jan―19 Potential Alternative Receptors for SARS-CoV-2-Induced Kidney Damage: TLR-4, KIM-1/TIM-1, and CD147 Nada J. Habeichi, Ghadir Amin, Bachir Lakkis, Rayane Kataya, Mathias Mericskay, George W. Booz, Fouad A. Zouein
5 [GO] 2023―Dec―01 Differential Expression Patterns of Toll-like Receptors in COVID-19 Patients Nawon Lee, Ryeojin Ko, Soo Young Lee
6 [GO] 2023―Nov―09 Identification of Whole-Blood DNA Methylation Signatures and Rules Associated with COVID-19 Severity Fei Yuan, JingXin Ren, HuiPing Liao, Wei Guo, Lei Chen, KaiYan Feng, et al. (+2)
7 [GO] 2023―Nov―01 SARS-CoV-2: The Virus, Its Biology and COVID-19 Disease-Counteracting Possibilities Rolf Marschalek
8 [GO] 2023―Sep―27 Impact of Immunosenescence on Viral Infections with an Emphasis on COVID-19 Giuseppe Murdaca, Francesca Paladin, Gabriella Martino, Sebastiano Gangemi
9 [GO] 2023―Jul―31 Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells Valentina Gentili, Daria Bortolotti, Luca Morandi, Sabrina Rizzo, Giovanna Schiuma, Silvia Beltrami, et al. (+5)
10 [GO] 2023―Apr―27 In Silico Optimization of SARS-CoV-2 Spike Specific Nanobodies Xiaohong Zhu, Ke An, Junfang Yan, Peiyi Xu, Chen Bai
11 [GO] 2023―Apr―27 Alterations of Fecal Metabolome Associated with BBIBP-CorV Vaccines against the SARS-CoV-2 Virus Ying Dong, Yang Shen, Pan Wang, Jie Jiao, Mulei Chen, Jing Li
12 [GO] 2023―Mar―20 The Role of Glutathione in Prevention of COVID-19 Immunothrombosis: A Review Ira Glassman, Nghia Le, Mercedeh Mirhosseini, Cheldon Alcantara, Aamna Asif, Anabel Goulding, et al. (+5)
13 [GO] 2023―Mar―03 B-Cell Receptor Features and Database Establishment in Recovered COVID-19 Patients by Combining 5'-RACE with PacBio Sequencing Zhu Zhu, Pingzhang Wang, Xiaodong Jia, Meng Yu, Huige Yan, Lei Liu, et al. (+14)
14 [GO] 2023―Feb―27 A Computational Approach in the Diagnostic Process of COVID-19: The Missing Link between the Laboratory and Emergency Department Luisa Lanzilao, Antonella Mariniello, Bianca Polenzani, Alessandra Aldinucci, Peiman Nazerian, Alessio Prota, et al. (+7)
15 [GO] 2023―Jan―13 Inhibition of SARS-CoV-2 Mpro with Vitamin C, L-Arginine and a Vitamin C/L-Arginine Combination Ivana Đukić, Nevena Kaličanin, Milan Sencanski, Snezana B. Pajovic, Jelena Milicevic, Jelena Prljic, et al. (+3)
16 [GO] 2022―Nov―30 Comparison of the Pathogenicity of SARS-CoV-2 Delta and Omicron Variants by Analyzing the Expression Patterns of Immune Response Genes in K18-hACE2 Transgenic Mice Kuruppu Arachchillage Praboda Priyangi Kuruppuarachchi, Yunyueng Jang, Sang Heui Seo
17 [GO] 2022―Nov―16 Aptamer-Mediated Antiviral Approaches for SARS-CoV-2 Kei Xian Tan, Jaison Jeevanandam, João Rodrigues, Michael K. Danquah
18 [GO] 2022―Oct―13 Role of Imaging and AI in the Evaluation of COVID-19 Infection: A Comprehensive Survey Mayada Elgendy, Hossam Magdy Balaha, Mohamed Shehata, Ahmed Alksas, Mahitab Ghoneim, Fatma Sherif, et al. (+6)
19 [GO] 2022―Oct―11 Characterization of the Intestinal Microbiome in Healthy Adults over Sars-Cov-2 Vaccination Jie Jiao, Yang Shen, Pan Wang, Kun Zuo, Xinchun Yang, Mulei Chen, et al. (+2)
20 [GO] 2022―Sep―09 Combination Therapies against COVID-19 Qunfeng Luo, Yunxi Zheng, Jin Zhang
21 [GO] 2022―Jul―14 Immunocytochemical Assessment of ACE2 and TMPRSS2 in Nasopharyngeal Swabs from SARS-CoV-2 Patients Karla Beatríz Peña, Josep Gumà, Carmen Guilarte, Lola Delamo, Marc Grifol, Berta Pique, et al. (+4)
22 [GO] 2022―Jul―01 Identification of DNA Methylation Signature and Rules for SARS-CoV-2 Associated with Age Lei Chen, Huiping Liao, Guohua Huang, Shijian Ding, Wei Guo, Tao Huang, Yudong Cai
23 [GO] 2022―Jun―24 COVIDx-US: An Open-Access Benchmark Dataset of Ultrasound Imaging Data for AI-Driven COVID-19 Analytics Ashkan Ebadi, Pengcheng Xi, Alexander MacLean, Adrian Florea, Stéphane Tremblay, Sonny Kohli, Alexander Wong
24 [GO] 2022―Jun―10 COVID-19 and H1N1-09: A Systematic Review of Two Pandemics with a Focus on the Lung at Autopsy Giuseppe Bertozzi, Michela Ferrara, Aniello Maiese, Nicola Di Fazio, Giuseppe Delogu, Paola Frati, et al. (+2)
25 [GO] 2022―Jun―10 Ginseng Protects ACE2-Transgenic Mice from SARS-CoV-2 Infection Sang Heui Seo
26 [GO] 2022―Jun―02 COVID-19 Lockdown Impacts Among Patients with Cystic Fibrosis: An Italian Regional Reference Centre Experience Alessandra Boni, Manuel Murciano, Francesca De Luca, Valentina Rizzo, Carlo Cappelli, Viviana D'Alé, et al. (+4)
27 [GO] 2022―May―20 The Potential Roles of BCG Vaccine in the Prevention or Treatment of COVID-19 Jie Wang, Qian Zhang, Hongmei Wang, Wenping Gong
28 [GO] 2022―May―20 Immunomodulatory and Anti-Inflammatory Effects of Berberine in Lung Tissue and its Potential Application in Prophylaxis and Treatment of COVID-19 Amin F. Majdalawieh, Sarah M. Yousef, Imad A. Abu-Yousef, Gheyath K. Nasrallah
29 [GO] 2022―Apr―14 Current Update of Phytotherapeutic Agents in the Treatment of COVID-19: In-Silico Based Virtual Screening Approach for the Development of Antiviral Drug Veena Ramesh, Seema A. Kulkarni, Palaniyandi Velusamy, Velmurugan Devadasan, Panneer Devaraju, Kandathil Narayanan Rajnish, et al. (+4)
30 [GO] 2022―Apr―14 Potential SARS-CoV-2 nonstructural proteins inhibitors: drugs repurposing with drug-target networks and deep learning Shayan K. Azmoodeh, Igor F. Tsigelny, Valentina L. Kouznetsova
31 [GO] 2022―Mar―18 Role of cytokine storm in coronavirus infections: culprit or accomplice? Rongpeng Xu, Cunming Liu, Xiaolin Xu, Yimin Hu, Bin Zhu, Chun Yang
32 [GO] 2022―Feb―25 COVID-19 and myocarditis: a brief review Fatma Taher, Athar Eysa, Dalia Fahmy, Ahmed Shalaby, Ali Mahmoud, Moumen El-Melegy, et al. (+2)
33 [GO] 2022―Jan―15 Combinatorial approach of vitamin C derivative and anti-HIV drug-darunavir against SARS-CoV-2 Alaka Sahoo, Shasank S. Swain, Biswaranjan Paital, Maitreyee Panda
34 [GO] 2022―Jan―15 Temporal evolution and adaptation of SARS-CoV-2 codon usage Elisa Posani, Maddalena Dilucca, Sergio Forcelloni, Athanasia Pavlopoulou, Alexandros G. Georgakilas, Andrea Giansanti
35 [GO] 2022―Jan―15 David Hunter Hubel, the ‘Circe effect’, and SARS-CoV-2 infection of the human visual system Walter J. Lukiw
36 [GO] 2022―Jan―15 UV-4B potently inhibits replication of multiple SARS-CoV-2 strains in clinically relevant human cell lines Evelyn J. Franco, Kelly L. Warfield, Ashley N. Brown
 [1] 

36 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec